0.26 (1.33%) 1d
Fulgent Genetics
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

We have some comments posted on FLGT. While it is not without potential, it is likely going to get worse before it bets better, growth-wise. The most recent quarterly earnings were fine as revenue continued to decline, but beat estimates, along with EPS. There are positives as the pharma side of the business is making progress with over 30 issued or active patents and a promising lead drug candidate. The balance sheet does continue to be strong. We are OK selling. 
Unlock Premium - Try 5i Free

Fulgent Genetics
They do genetic testing for rare diseases and other applications. They rolled out many tests during Covid, which became their major source of revenue (88%). Flush with that cash, they bought a company in August 2021, a good long-term opportunity in cancer testing. They didn't rest on their laurels. However, the market sees Fulgent as a Covid stock and has dumped it. Analysts expect their earnings to vanish in 2023. Do you believe in the rest of their business to have faith in it. He doesn't see much downside, but there's nothing urgent here to make him buy. He wants to see their Q4 numbers before making a movie. They have net cash of $900 million.
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Fulgent Genetics(FLGT-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 1

Stockchase rating for Fulgent Genetics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Fulgent Genetics(FLGT-Q) Frequently Asked Questions

What is Fulgent Genetics stock symbol?

Fulgent Genetics is a American stock, trading under the symbol FLGT-Q on the NASDAQ (FLGT). It is usually referred to as NASDAQ:FLGT or FLGT-Q

Is Fulgent Genetics a buy or a sell?

In the last year, 1 stock analyst published opinions about FLGT-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Fulgent Genetics.

Is Fulgent Genetics a good investment or a top pick?

Fulgent Genetics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Fulgent Genetics.

Why is Fulgent Genetics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Fulgent Genetics worth watching?

1 stock analyst on Stockchase covered Fulgent Genetics In the last year. It is a trending stock that is worth watching.

What is Fulgent Genetics stock price?

On 2024-06-18, Fulgent Genetics (FLGT-Q) stock closed at a price of $19.78.